13 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
of increasing responsibility at Novo Nordisk, most recently serving as Senior Vice President, Hemophilia R&D Portfolio. Dr. Prener previously served … . Dr. Shapiro served as Chief Medical Officer and head of R&D at Intercept Pharmaceuticals, Inc., a biopharmaceutical company, from April 2007 to May
8-K
nm2b9tst a3d
9 Feb 22
Departure of Directors or Certain Officers
4:30pm
DEF 14A
s74 acoklddhrvjz78
14 Apr 21
Definitive proxy
7:00am
10-K
l7rp0unp 0yxpmlqu20f
29 Mar 21
Annual report
6:03am
8-K
EX-99.1
wlwfk
8 Jan 21
Galecto Appoints Anne Prener to its Board of Directors
8:15am
424B4
yl18oo49l0lntbr5 rg
30 Oct 20
Prospectus supplement with pricing info
4:31pm
S-1/A
2inoq7h1hm p52
22 Oct 20
IPO registration (amended)
6:13am
S-1
fqqhp65
7 Oct 20
IPO registration
5:01pm
DRS
yzr29dbr9h9d
2 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next